share_log

新興市場銘柄ダイジェスト:WASHハウスは大幅反発、日本電解がストップ高

Emerging markets stock digest: WASH House has rebounded significantly, Japan Electrolytic has reached its upper limit.

Fisco Japan ·  Dec 6, 2024 07:02

<4054> Japan Information C 1174 -23

It fell back. After the trading ended on the 5th, it was announced that a capital and business alliance with Bcan would occur, starting the day with an increase, but it has fallen back due to the market conditions. Bcan is engaged in business related to employee welfare services and company housing consulting, with its primary focus on transactions with rental management companies, construction contractors, a-reit etf brokerage companies, and renovation contractors. It is thought that by merging Bcan's employee welfare services and company housing consulting services, it will contribute to the development of corporate value for both companies.

<5247> BTM 3010 -200

It continues to fall significantly. It was announced that it would participate in Amazon Web Services Japan's "AWS Japan Generative AI Practicalization Promotion Program," starting with a rebound, but it has continued to fall due to market conditions. The "AWS Japan Generative AI Practicalization Promotion Program" is an initiative to promote business innovation for customers utilizing generative AI. With this participation, they intend to leverage the technology of generative AI to provide optimal solutions in a wide range of areas including operational efficiency, improved customer experience, and the creation of new business models, alongside a network of development companies nationwide.

<5759> Japan Electrolytic 74 +30

It hit the upper limit. After the trading ended on November 27, it was announced that an application to start civil rehabilitation proceedings would be made, leading to a rush to sell; however, after updating the year’s low today, it has rebounded significantly due to a money game-like movement. The company was seeking support due to deteriorating performance, but no specific support targets were found, and it applied to the Tokyo District Court to start civil rehabilitation proceedings. The Tokyo Stock Exchange decided on the 27th to delist the company's stock and designated it as a monitored security. The delisting date is set for December 28.

<6027> Benri Lawyer 2602 -37

Fell back. After the trading session ended on the 5th, it was announced that Niigata City would start using the contract management platform "CloudSign" for electronic contract services. This marks the 6th implementation in a designated city. The share rate of CloudSign's implementation among municipalities nationwide is 70%, and it continues to promote nationwide electronic contracting as the number one electronic contract service in local governments. However, the response to the stock price has been limited.

<6537> WASH House 392 +57

A significant rebound. It was announced that a store with original washing machines and dryers developed in-house will open on December 26, 2024, which is viewed positively. The company group has been developing original washing machines and dryers necessary to realize their goal of providing free laundry since its founding, and the original washing machines and dryers have now been completed, allowing for the first container-type laundry store to open in Miyazaki Prefecture. Launching the new laundry machinery developed by the company into the market is expected to not only expand future business but also significantly change the industry's common practices.

<4599> Stem Rim 338 +12

Rebounded. A patent related to the peptide drug development candidate Ridacemide (a peptide drug created from HMGB1, development code: PJ1/S-005151) that has been licensed to Shionogi Pharmaceutical has been registered in Australia. This patent ensures that the company holds rights not only to Ridacemide but also to similar substances that may have regenerative induction effects or potentially possess them, thereby preventing the development of generics and imitations, securing the development advantage of regenerative drugs in the Australian market.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Comment Comment · Views 266

Recommended

Write a comment

Statement

This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.